HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
1 - 50 of 52
Dr. Gaetz uses magnetoencephalography (MEG) imaging to gain a deeper understanding of the neurobiology of cortical function in human health and disease. He has an interest in assessing the functional significance of somatosensory and motor cortical oscillations in children using MEG.
Dr. Galligan's operational and academic work are united by a fundamental goal of keeping patients, their families, and healthcare staff safe from harm. Dr. Galligan's current research focuses on applying principles of organizational behavior to the pediatric inpatient setting to prevent harm from unrecognized clinical deterioration.
Establishes a set of definitions, policies, and procedures to guide the involvement of individuals such as long-term collaborators, high school and college-level students, graduate students, and others who are not regular CHOP employees in the Research Institute’s programs.
Dr. George's basic and clinical research interests are in the development of novel therapeutics for hemophilia. Her basic science laboratory studies the molecular basis of coagulation, and she is the principal investigator of ongoing hemophilia A and B gene therapy trials.
Dr. Germiller is an attending surgeon and director of clinical research in the Division of Otolaryngology. His research interests include hearing loss in children, disorders of inner ear and auditory nerve development, cochlear implantation, congenital abnormalities, and genetics of hearing disorders.
Dr. Getz develops and applies advanced methods to enable epidemiologic research that aims to optimize the treatment and supportive care of children with cancer by balancing the therapeutic benefits and toxicity risks with an emphasis in cardio-oncology.
Dr. Ginsburg’s research focuses on facilitating youth to develop their own solutions to social problems and to teach clinicians how to better serve them. His current focus is on translating the best of what is known from research and practice into practical approaches parents, professionals, and communities can use to build resilience.
Dr. Glessner’s current research focuses on childhood neuropsychiatric and neurodevelopmental disorders along with the genetic architecture associated with them, including single nucleotide polymorphisms, single nucleotide variations, and copy number variations ascertained by genomic technologies.
Dr. Gmuca seeks to enhance the care of children with chronic musculoskeletal pain. Her current research addresses amplified musculoskeletal pain syndrome, which is a major public health issue because of its high prevalence, related socioeconomic burden, and associated risk of opioid exposure. Dr. Gmuca’s work aims to identify innovative strategies to improve long-term treatment outcomes for this patient population.
Dr. Goldberg's research program focuses on investigating cerebral cortical circuit function and dysfunction in neurodevelopmental disorders. Using a variety of research techniques, Dr. Goldberg has a specific research interest in the workings of neuron subtype called GABAergic inhibitory interneuron and the role of interneuron dysfunction in disease.
Dr. Goldberg's research focuses on children with single ventricle congenital heart disease. Much of his work centers on the consequences of the abnormal single ventricle physiology and the impact on other organ systems throughout the body. He is also interested in medical interventions designed to improve the efficiency of the post-Fontan circulation by lowering pulmonary vascular resistance.
Dr. Goldfarb has special interests in the treatment of children with end-stage lung disease such as cystic fibrosis, interstitial lung disease, pulmonary late effects of oncology treatments, and other pulmonary disorders.
Dr. Goldmuntz's research focuses on the genetic basis and modifiers of congenital heart disease, cardiomyopathy, and heart failure. Her goal is to identify genetic alterations conferring a risk for congenital heart disease and to correlate these findings with clinical outcomes. To this end, she is also performing clinical translational studies.
Alexander Gonzalez leads the DBHi Translational Research Informatics Group (TRiG), a team of data integration analysts and data scientists specializing in data integration solutions designed to manage complex rare disease data in biomedical research.
Dr. Gonzalez-Alegre's long-range research goal is to advance the application of precision medicine in the neurology clinic. His research focus revolves around genetic disorders that affect the brain, spanning from the diagnosis of novel genetic disease in the clinic to the identification of novel molecular targets using disease models and the design of early-phase human clinical trials.
Dr. Gordon is a basic immunologist and an attending physician in the Division of Neonatology who hopes to improve pre-, peri-, and post-natal outcomes for moms and babies by better understanding the immunology of the maternal-fetal interface.
Dr. Gottardi leads the Bioengineering and Biomaterials (Bio2) lab, collaborating on clinical and research efforts to offer engineering solutions for pediatric health, primarily treatments for airway disorders. Dr. Gottardi researches mechanisms of laryngotracheal pathologies, applies tissue engineering to improve pediatric conditions, develops new devices, and formulates controlled drug delivery systems to treat and improve patients’ lives.
Dr. Graci aims to identify the mechanisms underlying injury to inform strategies and interventions to reduce injury and improve safety. She leverages her eclectic scientific background, spanning from experimental psychology to exercise science and biomechanics. Her research focuses on biomechanical risk factors for age-related falls, and injury mechanisms due to motor vehicle accidents.
Dr. Gregory's overall career goal is to develop clinical programs to decrease rates of preterm birth. As a pediatric primary care physician-researcher, she seeks to leverage existing pediatric systems and opportunities for care to achieve this goal.
Dr. Heather Griffis leads a team of data managers, scientists, and methodologists who work with investigators to merge, clean, and structure data; provide analytic datasets; and apply appropriate methods to various data sources, in order to answer research questions that inform practice and policy.
Dr. Grimberg investigates the growth hormone (GH)/insulin-like growth factor (IGF)-I axis and clinical issues related to child growth. Her recent research is focused on disparities in, and the decision-making related to, the medical management of children with short stature. She is fascinated by how differential societal pressures for tallness and the advent of an expensive therapeutic have transformed a fundamental aspect of pediatric healthcare.
Dr. Grinspan's research program focuses on oligodendrocytes, cells of the central nervous system that synthesize the myelin sheath required for transmission of nervous impulses. Her research seeks to understand the signaling pathways that regulate oligodendrocyte maturation and how they are perturbed in diseases such as multiple sclerosis, HIV, and perinatal white matter injury.
Dr. Grundmeier’s research focuses on maximizing the existing and future potential of electronic health records (EHRs) for clinical research and knowledge delivery, with an overarching goal of improving health and healthcare for children.
Dr. Grupp develops and conducts preclinical testing of engineered cell therapies and signal transduction inhibitors in leukemia, in pediatric immunotherapy trials, and in the manufacture and use of cellular therapeutics in preclinical, good manufacturing practices, and clinical trial settings. Dr. Grupp leads most CTL019 (CD19 CAR) clinical trials, and his colleagues are the global leaders in highly active CAR T cell therapy.
Dr. Guerra is researching innovating therapies to treat β-thalassemia and sickle cell anemia and use lentiviruses as a tool. Her work aims to discover new biological targets that can be used to treat β-thalassemia and other forms of anemia.
Dr. Guevara is the principal investigator on research grants evaluating health inequities in early childhood development and behavioral problems. He utilizes community-based participatory clinical trials involving parent advocacy groups, community organizations, and government agencies to test the effects of psychosocial interventions designed to provide parents with resources and tools to improve the care of their children.